Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies.

Bishop FL, Rea A, Lewith H, Chan YK, Saville J, Prescott P, von Elm E, Lewith GT.

Prostate Cancer Prostatic Dis. 2011 Mar;14(1):1-13. doi: 10.1038/pcan.2010.38. Epub 2010 Oct 19. Review.

PMID:
20956994
2.

A systematic literature review of complementary and alternative medicine prevalence in EU.

Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos-Rey K, Vas J, von Ammon K, Hegyi G, Dragan S, Uehleke B, Fønnebø V, Lewith G.

Forsch Komplementmed. 2012;19 Suppl 2:18-28. doi: 10.1159/000342708. Review.

PMID:
23883941
3.

Prevalence of complementary medicine use in pediatric cancer: a systematic review.

Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT.

Pediatrics. 2010 Apr;125(4):768-76. doi: 10.1542/peds.2009-1775. Epub 2010 Mar 22. Review.

PMID:
20308209
4.

A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.

Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R.

Integr Cancer Ther. 2003 Sep;2(3):212-6.

PMID:
15035882
5.

Prevalence of complementary and alternative medicine (CAM) use by menopausal women: a systematic review of surveys.

Posadzki P, Lee MS, Moon TW, Choi TY, Park TY, Ernst E.

Maturitas. 2013 May;75(1):34-43. doi: 10.1016/j.maturitas.2013.02.005. Epub 2013 Mar 14. Review.

PMID:
23497959
6.

Prevalence of complementary and alternative medicine (CAM)-use in UK paediatric patients: a systematic review of surveys.

Posadzki P, Watson L, Alotaibi A, Ernst E.

Complement Ther Med. 2013 Jun;21(3):224-31. doi: 10.1016/j.ctim.2012.11.006. Epub 2013 Jan 9. Review.

PMID:
23642955
7.

Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.

Posadzki P, Watson LK, Alotaibi A, Ernst E.

Clin Med (Lond). 2013 Apr;13(2):126-31. doi: 10.7861/clinmedicine.13-2-126. Review.

PMID:
23681857
8.

Prevalence of use of complementary and alternative medicine (CAM) by physicians in the UK: a systematic review of surveys.

Posadzki P, Alotaibi A, Ernst E.

Clin Med (Lond). 2012 Dec;12(6):505-12. Review.

PMID:
23342401
9.

Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.

Boon H, Westlake K, Stewart M, Gray R, Fleshner N, Gavin A, Brown JB, Goel V.

Urology. 2003 Nov;62(5):849-53.

PMID:
14624907
10.

Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.

Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR.

Urology. 2005 Dec;66(6):1223-8.

PMID:
16360447
11.

Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.

Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF.

J Urol. 2003 Jul;170(1):166-9.

PMID:
12796672
12.

Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update.

Harris PE, Cooper KL, Relton C, Thomas KJ.

Int J Clin Pract. 2012 Oct;66(10):924-39. doi: 10.1111/j.1742-1241.2012.02945.x. Review.

PMID:
22994327
13.

Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.

Yoshimura K, Ichioka K, Terada N, Terai A, Arai Y.

Int J Clin Oncol. 2003 Feb;8(1):26-30.

PMID:
12601539
14.

Complementary and alternative medicine (CAM) use among men with a history of prostate cancer.

Ross LE, Fletcher A, Anderson MC, Meade SA, Powe BD, Howard D.

J Cult Divers. 2012 Winter;19(4):143-50.

PMID:
23362695
15.
16.

Prevalence of complementary and alternative medicine use in a community-based population in South Korea: a systematic review.

Seo HJ, Baek SM, Kim SG, Kim TH, Choi SM.

Complement Ther Med. 2013 Jun;21(3):260-71. doi: 10.1016/j.ctim.2013.03.001. Epub 2013 Mar 27. Review.

PMID:
23642959
17.
18.
19.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
20.

Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors.

Jones RA, Taylor AG, Bourguignon C, Steeves R, Fraser G, Lippert M, Theodorescu D, Mathews H, Kilbridge KL.

Oncol Nurs Forum. 2007 Mar;34(2):359-64.

Supplemental Content

Support Center